NuVasive Launches New Orthobiologic Products

NuVasive expanded its orthobiologic portfolio with U.S. launch of traditional bone allograft, Amniotic Membrane DS and additional form factors for the Propel™ DBM product line.

Allograft is available as cancellous chips, demineralized cancellous chips, cortical cancellous chips and cancellous crushed in a range of grind sizes and volumes.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us